Medical Communications

Showing 15 posts of 6408 posts found.

mouse

J&J bows to PETA pressure and drops forced swim tests in mice

March 21, 2019 Medical Communications J&J, JJ, Johnson & Johnson, PETA, animal welfare, pharma

Johnson & Johnson has announced it is to end its practice of forced swim tests on mice, rats and other …
mme_fb_event_banner_tangent_dj

Patient Experience: Living with two rare diseases

March 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wyburn-Mason Syndrome, acromegaly, feature, patient experience, pharma, rare disease

Dan Jeffries was diagnosed with the ultra-rare condition Wyburn-Mason syndrome at a young age, leaving him blind in one eye. …
mr058666-web

Merck KGaA enters drug discovery partnership with AI firm Itkos

March 15, 2019 Medical Communications, Research and Development AI, Merck, Merck KGaA, drug discovery, pharma

Merck KGaA and artificial intelligence (AI) firm Iktos have entered into a partnership, the pair have announced, to leverage the …
norman_sharpless_official_photo

National Cancer Institute Director Ned Sharpless to become interim FDA Commissioner

March 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of …
richard-francis-big-image_0

Sandoz CEO Richard Francis to step down

March 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …
images

Roche scores two EU approvals in haemophilia and rare autoimmune disease

March 15, 2019 Medical Communications EC, EU, Europe, Roche, haemophilia, rare diseases

The European Commission (EC) has approved Roche’s haemophilia treatment Hemlibra (emicizumab). The approval comes as the EC approved Roche’s MabThera …
merckwindow_web

MSD’s Keytruda/chemo combo nabs EU approval in first-line metastatic squamous lung cancer

March 15, 2019 Medical Communications, Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

MSD’s anti-PD-L1 therapy Keytruda (pembrolizumab) has been awarded marketing authorisation in Europe for the first-line treatment of adult patients with …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Acadia Pharmaceuticals, FDA, Sandoz, brexit, genomics, pharma, pharmacovigilance, top 10

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …
ianread

Pfizer CEO Ian Read’s pay packet cut from $27.9m to $19.5m

March 15, 2019 Medical Communications CEO, Ian Read, Pfizer, compensation, pay packet, salary

Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this …
richard-francis-big-image

Sandoz CEO Richard Francis to step down

March 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, Sandoz, appointment, pharma

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …

Califonia court rules J&J must pay woman with mesothelioma $29 million

March 14, 2019 Medical Communications, Sales and Marketing

A California jury has ordered American healthcare conglomerate Johnson & Johnson to pay more than $29 million to a woman …
norman_sharpless_official_photo

National Cancer Institute Director Ned Sharpless to become interim FDA Commissioner

March 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Ned Sharpless, Scott Gottlieb, appointment, pharma

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of …
28246711066_52e38bc591_z

Healthcare industry could take up to five years to stabilise after no-deal Brexit

March 13, 2019 Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …
tt-img-leadership-jennifer

Innate Pharma hires Jennifer Butlers to lead commercialisation of leukaemia drug Lumoxiti

March 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French company Innate Pharma have announced the appointment of Jennifer Butler to the position of Executive Vice President and General …

PV futures: Pharmacovigilance as a solution to the challenges of tomorrow

March 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, feature, pharma, pharmacovigilance

Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices …
The Gateway to Local Adoption Series

Latest content